Skip to main content
Porto

PMMNG logo

  • Home
  • News
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events

  • CancerCare: Current Perspectives on Cancer Survivorship
  • MMRF: Patient Summit – Virtual Web Conference
  • Myeloma Crowd: Multiple Myeloma Care in 2021
  • IMF: Best of ASH 2020
  • MMRF: Expert Session on Smoldering Myeloma
  • MMRF: Multiple Myeloma Highlights From the 2020 American Society of Hematology (ASH) Meeting & Exposition
  • Myeloma Crowd: The IMPACT of COVID-19 on MGUS, Smoldering Myeloma, African Americans and Myeloma Patient Family Members
  • CancerCare: Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
  • IMF: IMWG Conference Series - ASH 2020
  • CancerCare: How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer

Myeloma Crowd: New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg

Myeloma Crowd LogoWhat: Webcast audio (1:01:09) and transcript
When: Monday June 19, 2017
Where: Web
More Info: https://www.myelomacrowd.org/full-show-new-bi-specific-antibody-hitting-two-targets-in-myeloma-dirk-hose-md-and-anja-seckinger-md-university-of-heidelberg/

Tags
event
archived
myeloma crowd
webcast
audio
research
immunotherapy
antibody